Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ACADIA Pharmaceuticals Inc ACAD

Healthcare Biotechnology
Acadia Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has a portfolio of commercial stage products, in-development product opportunities, and research programs that are designed to address unmet needs in CNS disorders... see more

Recent & Breaking News (NDAQ:ACAD)

ACADIA Pharmaceuticals to Announce Fourth Quarter and Full Year 2016 Financial Results on February 28, 2017

Business Wire February 21, 2017

Biotech Stocks under Scanner -- ACADIA Pharma, Clovis Oncology, Galena Biopharma, and Northwest Biotherapeutics

PR Newswire February 21, 2017

Wall Street's M&A Chatter From February 3-6

Benzinga.com  February 6, 2017

Technical Reports on Biotech Stocks -- Clovis Oncology, Galena Biopharma, and ACADIA Pharma

PR Newswire January 13, 2017

Wall Street's M&A Chatter From January 4

Benzinga.com  January 5, 2017

ACADIA Pharmaceuticals to Present at the 35th Annual J.P. Morgan Healthcare Conference on January 10, 2017

Business Wire January 3, 2017

Investors: Get options trading reports for ACADIA Pharmaceuticals, Advanced Micro Devices, Allegheny Technologies, Host Hotels and Resorts and Microsoft include trade ideas that offer returns of 21% or more!

PR Newswire December 21, 2016

Biotech Stocks Head Into 2017 With Clinical Developments That Could Lead to Growth and Added Value

PR Newswire December 21, 2016

Acadia's Positive Data News May Have Triggered Short Squeeze

Benzinga.com  December 20, 2016

ACADIA Pharmaceuticals Announces Positive Top-Line Results From Phase II Study of Pimavanserin for Alzheimer’s Disease Psychosis

Business Wire December 20, 2016

InvestorsObserver releases covered-call reports for Freeport-McMoRan, Pandora, The Home Depot Inc., US Steel and ACADIA Pharmaceuticals

PR Newswire December 5, 2016

Biotech Stocks on Investors' Radar -- Northwest Biotherapeutics, ACADIA Pharma, Acorda Therapeutics, and Ultragenyx Pharma

PR Newswire December 5, 2016

ACADIA Pharmaceuticals Initiates Phase II Trial of Pimavanserin for Adjunctive Treatment in Patients With Major Depressive Disorder

Business Wire December 1, 2016

5 BioPharma Catalysts Expected Around Christmas

Benzinga.com  November 27, 2016

ACADIA Pharmaceuticals Initiates Phase II Trial of Pimavanserin for Adjunctive Treatment in Patients With Negative Symptoms of Schizophrenia

Business Wire November 15, 2016

The Market In 5 Minutes: You Don't Really Care For Music, Do You?

Benzinga.com  November 11, 2016

4 Election-Proof Stocks: Biotech And Software Take The Lead

Benzinga.com  November 8, 2016

15 Biggest Mid-Day Gainers For Tuesday

Benzinga.com  November 8, 2016

Benzinga's Volume Movers

Benzinga.com  November 8, 2016

ACADIA Pharmaceuticals Reports Third Quarter 2016 Financial Results

Business Wire November 7, 2016